APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biodegradable Embolic Microspheres

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biodegradable Embolic Microspheres Market Outlook and Growth Opportunities 2026

24 December 2025209 pages

Choose your research edition.

Industry ResearchBiodegradable Embolic Microspheres Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Biodegradable Embolic Microspheres Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Biodegradable Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biodegradable Embolic Microspheres Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Biodegradable Embolic Microspheres Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Biodegradable Embolic Microspheres market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biodegradable Embolic Microspheres market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biodegradable Embolic Microspheres market include Varian, Jiangsu Hengrui Medicine, Terumo Corporation, Tepha, Teleflex, Promedics AG, Occlugel, Nippon Kayaku and Next Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biodegradable Embolic Microspheres market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biodegradable Embolic Microspheres and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biodegradable Embolic Microspheres sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biodegradable Embolic Microspheres market size, projected growth trends, production technologies, key applications, and end-use industries.

Biodegradable Embolic Microspheres Segment by Company

Varian

Jiangsu Hengrui Medicine

Terumo Corporation

Tepha

Teleflex

Promedics AG

Occlugel

Nippon Kayaku

Next Biomedical

Mermaid Medical

Merit Medical Systems

CeloNova BioSciences

BTG Corporate

Biosphere Medical

Biocompatibles

Angio Dynamics

ABK Biomedical

Biodegradable Embolic Microspheres Segment by Type

Visualization Type

Environmentally Responsive Type

Radioactive Type

Other

Biodegradable Embolic Microspheres Segment by Application

Research Institution

Hospitals And Clinics

Biodegradable Embolic Microspheres Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biodegradable Embolic Microspheres status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biodegradable Embolic Microspheres market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biodegradable Embolic Microspheres significant trends, drivers, influence factors in global and regions.

6. To analyze Biodegradable Embolic Microspheres competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Embolic Microspheres.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biodegradable Embolic Microspheres market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biodegradable Embolic Microspheres industry.

Chapter 3: Detailed analysis of Biodegradable Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biodegradable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biodegradable Embolic Microspheres in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biodegradable Embolic Microspheres Industry Trends Table 2. Biodegradable Embolic Microspheres Industry Drivers Table 3. Biodegradable Embolic Microspheres Industry Opportunities and Challenges Table 4. Biodegradable Embolic Microspheres Industry Restraints Table 5. Global Biodegradable Embolic Microspheres Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biodegradable Embolic Microspheres Revenue Share by Company (2021-2026) Table 7. Global Biodegradable Embolic Microspheres Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Biodegradable Embolic Microspheres Sales Volume Share by Company (2021-2026) Table 9. Global Biodegradable Embolic Microspheres Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Biodegradable Embolic Microspheres Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biodegradable Embolic Microspheres Key Company Manufacturing Base & Headquarters Table 12. Global Biodegradable Embolic Microspheres Company, Product Type & Application Table 13. Global Biodegradable Embolic Microspheres Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biodegradable Embolic Microspheres by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Visualization Type Table 18. Significant Companies of Environmentally Responsive Type Table 19. Significant Companies of Radioactive Type Table 20. Significant Companies of Other Table 21. Global Biodegradable Embolic Microspheres Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Biodegradable Embolic Microspheres Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Biodegradable Embolic Microspheres Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Biodegradable Embolic Microspheres Sales Volume Share by Type (2021-2026) Table 25. Global Biodegradable Embolic Microspheres Sales Volume Share by Type (2027-2032) Table 26. Global Biodegradable Embolic Microspheres Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biodegradable Embolic Microspheres Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Biodegradable Embolic Microspheres Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Biodegradable Embolic Microspheres Sales Value Share by Type (2021-2026) Table 30. Global Biodegradable Embolic Microspheres Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Research Institution Table 32. Significant Companies of Hospitals And Clinics Table 33. Global Biodegradable Embolic Microspheres Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Biodegradable Embolic Microspheres Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Biodegradable Embolic Microspheres Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Biodegradable Embolic Microspheres Sales Volume Share by Application (2021-2026) Table 37. Global Biodegradable Embolic Microspheres Sales Volume Share by Application (2027-2032) Table 38. Global Biodegradable Embolic Microspheres Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Biodegradable Embolic Microspheres Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Biodegradable Embolic Microspheres Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Biodegradable Embolic Microspheres Sales Value Share by Application (2021-2026) Table 42. Global Biodegradable Embolic Microspheres Sales Value Share by Application (2027-2032) Table 43. Global Biodegradable Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Biodegradable Embolic Microspheres Sales by Region (2021-2026) & (Tons) Table 45. Global Biodegradable Embolic Microspheres Sales Market Share by Region (2021-2026) Table 46. Global Biodegradable Embolic Microspheres Sales by Region (2027-2032) & (Tons) Table 47. Global Biodegradable Embolic Microspheres Sales Market Share by Region (2027-2032) Table 48. Global Biodegradable Embolic Microspheres Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Biodegradable Embolic Microspheres Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Biodegradable Embolic Microspheres Sales Value Share by Region (2021-2026) Table 51. Global Biodegradable Embolic Microspheres Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Biodegradable Embolic Microspheres Sales Value Share by Region (2027-2032) Table 53. Global Biodegradable Embolic Microspheres Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Biodegradable Embolic Microspheres Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Biodegradable Embolic Microspheres Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Biodegradable Embolic Microspheres Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 58. Global Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2026) Table 59. Global Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 60. Global Biodegradable Embolic Microspheres Sales Market Share by Country (2027-2032) Table 61. Global Biodegradable Embolic Microspheres Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Biodegradable Embolic Microspheres Sales Value Market Share by Country (2021-2026) Table 63. Global Biodegradable Embolic Microspheres Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Biodegradable Embolic Microspheres Sales Value Market Share by Country (2027-2032) Table 65. Varian Company Information Table 66. Varian Business Overview Table 67. Varian Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Varian Biodegradable Embolic Microspheres Product Portfolio Table 69. Varian Recent Development Table 70. Jiangsu Hengrui Medicine Company Information Table 71. Jiangsu Hengrui Medicine Business Overview Table 72. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio Table 74. Jiangsu Hengrui Medicine Recent Development Table 75. Terumo Corporation Company Information Table 76. Terumo Corporation Business Overview Table 77. Terumo Corporation Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio Table 79. Terumo Corporation Recent Development Table 80. Tepha Company Information Table 81. Tepha Business Overview Table 82. Tepha Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Tepha Biodegradable Embolic Microspheres Product Portfolio Table 84. Tepha Recent Development Table 85. Teleflex Company Information Table 86. Teleflex Business Overview Table 87. Teleflex Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Teleflex Biodegradable Embolic Microspheres Product Portfolio Table 89. Teleflex Recent Development Table 90. Promedics AG Company Information Table 91. Promedics AG Business Overview Table 92. Promedics AG Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Promedics AG Biodegradable Embolic Microspheres Product Portfolio Table 94. Promedics AG Recent Development Table 95. Occlugel Company Information Table 96. Occlugel Business Overview Table 97. Occlugel Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Occlugel Biodegradable Embolic Microspheres Product Portfolio Table 99. Occlugel Recent Development Table 100. Nippon Kayaku Company Information Table 101. Nippon Kayaku Business Overview Table 102. Nippon Kayaku Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio Table 104. Nippon Kayaku Recent Development Table 105. Next Biomedical Company Information Table 106. Next Biomedical Business Overview Table 107. Next Biomedical Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Next Biomedical Biodegradable Embolic Microspheres Product Portfolio Table 109. Next Biomedical Recent Development Table 110. Mermaid Medical Company Information Table 111. Mermaid Medical Business Overview Table 112. Mermaid Medical Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio Table 114. Mermaid Medical Recent Development Table 115. Merit Medical Systems Company Information Table 116. Merit Medical Systems Business Overview Table 117. Merit Medical Systems Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio Table 119. Merit Medical Systems Recent Development Table 120. CeloNova BioSciences Company Information Table 121. CeloNova BioSciences Business Overview Table 122. CeloNova BioSciences Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio Table 124. CeloNova BioSciences Recent Development Table 125. BTG Corporate Company Information Table 126. BTG Corporate Business Overview Table 127. BTG Corporate Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. BTG Corporate Biodegradable Embolic Microspheres Product Portfolio Table 129. BTG Corporate Recent Development Table 130. Biosphere Medical Company Information Table 131. Biosphere Medical Business Overview Table 132. Biosphere Medical Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio Table 134. Biosphere Medical Recent Development Table 135. Biocompatibles Company Information Table 136. Biocompatibles Business Overview Table 137. Biocompatibles Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. Biocompatibles Biodegradable Embolic Microspheres Product Portfolio Table 139. Biocompatibles Recent Development Table 140. Angio Dynamics Company Information Table 141. Angio Dynamics Business Overview Table 142. Angio Dynamics Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio Table 144. Angio Dynamics Recent Development Table 145. ABK Biomedical Company Information Table 146. ABK Biomedical Business Overview Table 147. ABK Biomedical Biodegradable Embolic Microspheres Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 148. ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio Table 149. ABK Biomedical Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Biodegradable Embolic Microspheres Distributors List Table 153. Biodegradable Embolic Microspheres Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Biodegradable Embolic Microspheres Product Image Figure 2. Global Biodegradable Embolic Microspheres Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biodegradable Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biodegradable Embolic Microspheres Sales (2021-2032) & (Tons) Figure 5. Global Biodegradable Embolic Microspheres Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Biodegradable Embolic Microspheres Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Visualization Type Image Figure 10. Environmentally Responsive Type Image Figure 11. Radioactive Type Image Figure 12. Other Image Figure 13. Global Biodegradable Embolic Microspheres Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Biodegradable Embolic Microspheres Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Biodegradable Embolic Microspheres Sales Volume Share by Type (2021-2032) Figure 16. Global Biodegradable Embolic Microspheres Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biodegradable Embolic Microspheres Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Biodegradable Embolic Microspheres Sales Value Share by Type (2021-2032) Figure 19. Research Institution Image Figure 20. Hospitals And Clinics Image Figure 21. Global Biodegradable Embolic Microspheres Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Biodegradable Embolic Microspheres Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Biodegradable Embolic Microspheres Sales Volume Share by Application (2021-2032) Figure 24. Global Biodegradable Embolic Microspheres Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Biodegradable Embolic Microspheres Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Biodegradable Embolic Microspheres Sales Value Share by Application (2021-2032) Figure 27. Global Biodegradable Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Biodegradable Embolic Microspheres Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Biodegradable Embolic Microspheres Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Biodegradable Embolic Microspheres Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Biodegradable Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 32. North America Biodegradable Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Biodegradable Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Biodegradable Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Biodegradable Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Biodegradable Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Biodegradable Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 38. South America Biodegradable Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Biodegradable Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Biodegradable Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Biodegradable Embolic Microspheres Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Biodegradable Embolic Microspheres Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Visualization Type
  • Environmentally Responsive Type
  • Radioactive Type
  • Other
Applications
  • Research Institution
  • Hospitals And Clinics
Companies covered
  • Varian
  • Jiangsu Hengrui Medicine
  • Terumo Corporation
  • Tepha
  • Teleflex
  • Promedics AG
  • Occlugel
  • Nippon Kayaku
  • Next Biomedical
  • Mermaid Medical
  • Merit Medical Systems
  • CeloNova BioSciences
  • BTG Corporate
  • Biosphere Medical
  • Biocompatibles
  • Angio Dynamics
  • ABK Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biodegradable Embolic Microspheres Sales Value (2021-2032)
  4. 1.2.2 Global Biodegradable Embolic Microspheres Sales Volume (2021-2032)
  5. 1.2.3 Global Biodegradable Embolic Microspheres Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biodegradable Embolic Microspheres Market Dynamics
  1. 2.1 Biodegradable Embolic Microspheres Industry Trends
  2. 2.2 Biodegradable Embolic Microspheres Industry Drivers
  3. 2.3 Biodegradable Embolic Microspheres Industry Opportunities and Challenges
  4. 2.4 Biodegradable Embolic Microspheres Industry Restraints
3 Biodegradable Embolic Microspheres Market by Company
  1. 3.1 Global Biodegradable Embolic Microspheres Company Revenue Ranking in 2025
  2. 3.2 Global Biodegradable Embolic Microspheres Revenue by Company (2021-2026)
  3. 3.3 Global Biodegradable Embolic Microspheres Sales Volume by Company (2021-2026)
  4. 3.4 Global Biodegradable Embolic Microspheres Average Price by Company (2021-2026)
  5. 3.5 Global Biodegradable Embolic Microspheres Company Ranking (2024-2026)
  6. 3.6 Global Biodegradable Embolic Microspheres Company Manufacturing Base and Headquarters
  7. 3.7 Global Biodegradable Embolic Microspheres Company Product Type and Application
  8. 3.8 Global Biodegradable Embolic Microspheres Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biodegradable Embolic Microspheres Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biodegradable Embolic Microspheres Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biodegradable Embolic Microspheres Market by Type
  1. 4.1 Biodegradable Embolic Microspheres Type Introduction
  2. 4.1.1 Visualization Type
  3. 4.1.2 Environmentally Responsive Type
  4. 4.1.3 Radioactive Type
  5. 4.1.4 Other
  6. 4.2 Global Biodegradable Embolic Microspheres Sales Volume by Type
  7. 4.2.1 Global Biodegradable Embolic Microspheres Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biodegradable Embolic Microspheres Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Biodegradable Embolic Microspheres Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Biodegradable Embolic Microspheres Sales Value by Type
  11. 4.3.1 Global Biodegradable Embolic Microspheres Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Biodegradable Embolic Microspheres Sales Value by Type (2021-2032)
  13. 4.3.3 Global Biodegradable Embolic Microspheres Sales Value Share by Type (2021-2032)
5 Biodegradable Embolic Microspheres Market by Application
  1. 5.1 Biodegradable Embolic Microspheres Application Introduction
  2. 5.1.1 Research Institution
  3. 5.1.2 Hospitals And Clinics
  4. 5.2 Global Biodegradable Embolic Microspheres Sales Volume by Application
  5. 5.2.1 Global Biodegradable Embolic Microspheres Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biodegradable Embolic Microspheres Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Biodegradable Embolic Microspheres Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Biodegradable Embolic Microspheres Sales Value by Application
  9. 5.3.1 Global Biodegradable Embolic Microspheres Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Biodegradable Embolic Microspheres Sales Value by Application (2021-2032)
  11. 5.3.3 Global Biodegradable Embolic Microspheres Sales Value Share by Application (2021-2032)
6 Biodegradable Embolic Microspheres Regional Sales and Value Analysis
  1. 6.1 Global Biodegradable Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biodegradable Embolic Microspheres Sales by Region (2021-2032)
  3. 6.2.1 Global Biodegradable Embolic Microspheres Sales by Region: 2021-2026
  4. 6.2.2 Global Biodegradable Embolic Microspheres Sales by Region (2027-2032)
  5. 6.3 Global Biodegradable Embolic Microspheres Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biodegradable Embolic Microspheres Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biodegradable Embolic Microspheres Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biodegradable Embolic Microspheres Sales Value by Region (2027-2032)
  9. 6.5 Global Biodegradable Embolic Microspheres Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biodegradable Embolic Microspheres Sales Value (2021-2032)
  12. 6.6.2 North America Biodegradable Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biodegradable Embolic Microspheres Sales Value (2021-2032)
  15. 6.7.2 Europe Biodegradable Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biodegradable Embolic Microspheres Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biodegradable Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biodegradable Embolic Microspheres Sales Value (2021-2032)
  21. 6.9.2 South America Biodegradable Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biodegradable Embolic Microspheres Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biodegradable Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
7 Biodegradable Embolic Microspheres Country-level Sales and Value Analysis
  1. 7.1 Global Biodegradable Embolic Microspheres Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biodegradable Embolic Microspheres Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  4. 7.3.1 Global Biodegradable Embolic Microspheres Sales by Country (2021-2026)
  5. 7.3.2 Global Biodegradable Embolic Microspheres Sales by Country (2027-2032)
  6. 7.4 Global Biodegradable Embolic Microspheres Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biodegradable Embolic Microspheres Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biodegradable Embolic Microspheres Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biodegradable Embolic Microspheres Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biodegradable Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biodegradable Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Varian
  2. 8.1.1 Varian Company Information
  3. 8.1.2 Varian Business Overview
  4. 8.1.3 Varian Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Varian Biodegradable Embolic Microspheres Product Portfolio
  6. 8.1.5 Varian Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine
  8. 8.2.1 Jiangsu Hengrui Medicine Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Recent Developments
  13. 8.3 Terumo Corporation
  14. 8.3.1 Terumo Corporation Company Information
  15. 8.3.2 Terumo Corporation Business Overview
  16. 8.3.3 Terumo Corporation Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio
  18. 8.3.5 Terumo Corporation Recent Developments
  19. 8.4 Tepha
  20. 8.4.1 Tepha Company Information
  21. 8.4.2 Tepha Business Overview
  22. 8.4.3 Tepha Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tepha Biodegradable Embolic Microspheres Product Portfolio
  24. 8.4.5 Tepha Recent Developments
  25. 8.5 Teleflex
  26. 8.5.1 Teleflex Company Information
  27. 8.5.2 Teleflex Business Overview
  28. 8.5.3 Teleflex Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teleflex Biodegradable Embolic Microspheres Product Portfolio
  30. 8.5.5 Teleflex Recent Developments
  31. 8.6 Promedics AG
  32. 8.6.1 Promedics AG Company Information
  33. 8.6.2 Promedics AG Business Overview
  34. 8.6.3 Promedics AG Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Promedics AG Biodegradable Embolic Microspheres Product Portfolio
  36. 8.6.5 Promedics AG Recent Developments
  37. 8.7 Occlugel
  38. 8.7.1 Occlugel Company Information
  39. 8.7.2 Occlugel Business Overview
  40. 8.7.3 Occlugel Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Occlugel Biodegradable Embolic Microspheres Product Portfolio
  42. 8.7.5 Occlugel Recent Developments
  43. 8.8 Nippon Kayaku
  44. 8.8.1 Nippon Kayaku Company Information
  45. 8.8.2 Nippon Kayaku Business Overview
  46. 8.8.3 Nippon Kayaku Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio
  48. 8.8.5 Nippon Kayaku Recent Developments
  49. 8.9 Next Biomedical
  50. 8.9.1 Next Biomedical Company Information
  51. 8.9.2 Next Biomedical Business Overview
  52. 8.9.3 Next Biomedical Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Next Biomedical Biodegradable Embolic Microspheres Product Portfolio
  54. 8.9.5 Next Biomedical Recent Developments
  55. 8.10 Mermaid Medical
  56. 8.10.1 Mermaid Medical Company Information
  57. 8.10.2 Mermaid Medical Business Overview
  58. 8.10.3 Mermaid Medical Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio
  60. 8.10.5 Mermaid Medical Recent Developments
  61. 8.11 Merit Medical Systems
  62. 8.11.1 Merit Medical Systems Company Information
  63. 8.11.2 Merit Medical Systems Business Overview
  64. 8.11.3 Merit Medical Systems Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio
  66. 8.11.5 Merit Medical Systems Recent Developments
  67. 8.12 CeloNova BioSciences
  68. 8.12.1 CeloNova BioSciences Company Information
  69. 8.12.2 CeloNova BioSciences Business Overview
  70. 8.12.3 CeloNova BioSciences Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio
  72. 8.12.5 CeloNova BioSciences Recent Developments
  73. 8.13 BTG Corporate
  74. 8.13.1 BTG Corporate Company Information
  75. 8.13.2 BTG Corporate Business Overview
  76. 8.13.3 BTG Corporate Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 BTG Corporate Biodegradable Embolic Microspheres Product Portfolio
  78. 8.13.5 BTG Corporate Recent Developments
  79. 8.14 Biosphere Medical
  80. 8.14.1 Biosphere Medical Company Information
  81. 8.14.2 Biosphere Medical Business Overview
  82. 8.14.3 Biosphere Medical Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio
  84. 8.14.5 Biosphere Medical Recent Developments
  85. 8.15 Biocompatibles
  86. 8.15.1 Biocompatibles Company Information
  87. 8.15.2 Biocompatibles Business Overview
  88. 8.15.3 Biocompatibles Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Biocompatibles Biodegradable Embolic Microspheres Product Portfolio
  90. 8.15.5 Biocompatibles Recent Developments
  91. 8.16 Angio Dynamics
  92. 8.16.1 Angio Dynamics Company Information
  93. 8.16.2 Angio Dynamics Business Overview
  94. 8.16.3 Angio Dynamics Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio
  96. 8.16.5 Angio Dynamics Recent Developments
  97. 8.17 ABK Biomedical
  98. 8.17.1 ABK Biomedical Company Information
  99. 8.17.2 ABK Biomedical Business Overview
  100. 8.17.3 ABK Biomedical Biodegradable Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio
  102. 8.17.5 ABK Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biodegradable Embolic Microspheres Value Chain Analysis
  2. 9.1.1 Biodegradable Embolic Microspheres Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biodegradable Embolic Microspheres Sales Mode & Process
  6. 9.2 Biodegradable Embolic Microspheres Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biodegradable Embolic Microspheres Distributors
  9. 9.2.3 Biodegradable Embolic Microspheres Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst